Crossmark

Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapy

Crossref DOI link: https://doi.org/10.1186/s13014-022-02018-1

Published Online: 2022-03-05

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiang, Xiaoyong

Ding, Zhen

Zeng, Qi

Feng, Lingling

Qiu, Chunyan

Chen, Dongjie

Lu, Jiawei

Li, Ning
Funding

Funding for this research was provided by:

Sanming Project of Medicine in Shenzhen (SZSM201612063)

Shenzhen Key Medical Discipline Construction Fund (SZXK013)
License Information

Text and Data Mining valid from 2022-03-05

Version of Record valid from 2022-03-05
More Information

Article History

Received: 12 October 2021

Accepted: 23 February 2022

First Online: 5 March 2022

Declarations

:

: The study was approved by the ethics committee of The Cancer Hospital & Shenzhen Hospital.

: Not applicable.

: None of the authors have any conflicts of interest to declare.

Document is current

Any future updates will be listed below